NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CFO Jay Matushak sold 4,970 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10. Following the sale, the chief financial officer now directly owns 17,747 shares of the company's stock, valued at approximately $130,085.51. This represents a 21.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
NeueHealth Stock Up 0.7 %
Shares of NYSE NEUE traded up $0.05 during mid-day trading on Wednesday, hitting $7.45. 38,124 shares of the company traded hands, compared to its average volume of 70,685. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59. The stock has a market capitalization of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57. The business has a 50 day moving average of $5.47 and a two-hundred day moving average of $5.38.
Institutional Trading of NeueHealth
A number of hedge funds have recently bought and sold shares of the company. NEA Management Company LLC acquired a new stake in shares of NeueHealth in the second quarter worth $14,834,000. Deer Management Co. LLC acquired a new position in NeueHealth during the second quarter valued at $5,436,000. Partners Group Holding AG purchased a new stake in NeueHealth in the 3rd quarter worth about $463,000. Finally, Renaissance Technologies LLC acquired a new stake in NeueHealth during the 2nd quarter worth about $312,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada dropped their price target on NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a report on Monday, December 9th.
View Our Latest Stock Analysis on NEUE
About NeueHealth
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.